pubmed-article:14744281 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C0004114 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C1334751 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C1512554 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:14744281 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:14744281 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:14744281 | pubmed:dateCreated | 2004-1-27 | lld:pubmed |
pubmed-article:14744281 | pubmed:abstractText | O(6)-Methylguanine-deoxyribonucleic acid methyltransferase (MGMT) is a deoxyribonucleic acid repair protein associated with the chemoresistance of chloroethylnitrosoureas. We investigated whether MGMT promoter hypermethylation is associated with prognosis in patients with high-grade astrocytic tumors treated uniformly with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-based chemotherapy. | lld:pubmed |
pubmed-article:14744281 | pubmed:language | eng | lld:pubmed |
pubmed-article:14744281 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14744281 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14744281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14744281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14744281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14744281 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14744281 | pubmed:month | Feb | lld:pubmed |
pubmed-article:14744281 | pubmed:issn | 0148-396X | lld:pubmed |
pubmed-article:14744281 | pubmed:author | pubmed-author:UshioYukitaka... | lld:pubmed |
pubmed-article:14744281 | pubmed:author | pubmed-author:TadaKenjiK | lld:pubmed |
pubmed-article:14744281 | pubmed:author | pubmed-author:KamiryoTakano... | lld:pubmed |
pubmed-article:14744281 | pubmed:author | pubmed-author:ShiraishiShoj... | lld:pubmed |
pubmed-article:14744281 | pubmed:author | pubmed-author:ShinojimaNaok... | lld:pubmed |
pubmed-article:14744281 | pubmed:author | pubmed-author:KochiMasatoM | lld:pubmed |
pubmed-article:14744281 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14744281 | pubmed:volume | 54 | lld:pubmed |
pubmed-article:14744281 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14744281 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14744281 | pubmed:pagination | 349-57; discussion 357 | lld:pubmed |
pubmed-article:14744281 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:meshHeading | pubmed-meshheading:14744281... | lld:pubmed |
pubmed-article:14744281 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:14744281 | pubmed:articleTitle | Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea-based chemotherapy. | lld:pubmed |
pubmed-article:14744281 | pubmed:affiliation | Department of Neurosurgery, Kumamoto University School of Medicine, Kumamoto, Japan. tkamiryo-nsu@umin.ac.jp | lld:pubmed |
pubmed-article:14744281 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14744281 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14744281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14744281 | lld:pubmed |